The Vanguard Group 13D and 13G filings for AbbVie Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-07 1:20 pm Purchase | 2025-06-30 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 177,266,703 10.030% | 16,886,646 (+10.53%) | Filing |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 160,380,057 9.080% | 2,062,505 (+1.30%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 158,317,552 8.950% | 12,005,483 (+8.21%) | Filing |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 146,312,069 8.280% | 3,748,995 (+2.63%) | Filing |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 142,563,074 8.080% | 19,988,354 (+16.31%) | Filing |